Annual Shareholders Equity:
-$1.10B-$279.52M(-34.15%)Summary
- As of today, PTCT annual stockholders equity is -$1.10 billion, with the most recent change of -$279.52 million (-34.15%) on December 31, 2024.
- During the last 3 years, PTCT annual shareholders equity has fallen by -$1.10 billion (-76460.99%).
- PTCT annual shareholders equity is now -284.76% below its all-time high of $594.33 million, reached on December 31, 2019.
Performance
PTCT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Shareholders Equity:
-$206.55M-$20.79M(-11.19%)Summary
- As of today, PTCT quarterly stockholders equity is -$206.55 million, with the most recent change of -$20.79 million (-11.19%) on June 30, 2025.
- Over the past year, PTCT quarterly shareholders equity has increased by +$773.63 million (+78.93%).
- PTCT quarterly shareholders equity is now -131.12% below its all-time high of $663.65 million, reached on September 30, 2019.
Performance
PTCT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PTCT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -34.1% | +78.9% |
| 3Y3 Years | -10000.0% | -13.3% |
| 5Y5 Years | -284.8% | -136.1% |
PTCT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | >-9999.0% | at low | -11.2% | +81.2% |
| 5Y | 5-Year | -284.8% | at low | -140.4% | +81.2% |
| All-Time | All-Time | -284.8% | at low | -131.1% | +81.2% |
PTCT Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$206.55M(-11.2%) |
| Mar 2025 | - | -$185.76M(+83.1%) |
| Dec 2024 | -$1.10B(-34.1%) | -$1.10B(-4.1%) |
| Sep 2024 | - | -$1.05B(-7.6%) |
| Jun 2024 | - | -$980.18M(-9.7%) |
| Mar 2024 | - | -$893.92M(-9.2%) |
| Dec 2023 | -$818.55M(-135.8%) | -$818.55M(-22.0%) |
| Sep 2023 | - | -$670.81M(-15.8%) |
| Jun 2023 | - | -$579.27M(-26.6%) |
| Mar 2023 | - | -$457.56M(-31.8%) |
| Dec 2022 | -$347.09M(>-9900.0%) | -$347.09M(-53.0%) |
| Sep 2022 | - | -$226.90M(-24.5%) |
| Jun 2022 | - | -$182.22M(-101.2%) |
| Mar 2022 | - | -$90.58M(-6399.1%) |
| Dec 2021 | $1.44M(-99.7%) | $1.44M(-98.6%) |
| Sep 2021 | - | $104.93M(-46.6%) |
| Jun 2021 | - | $196.58M(-32.8%) |
| Mar 2021 | - | $292.58M(-39.3%) |
| Dec 2020 | $481.98M(-18.9%) | $481.98M(-5.7%) |
| Sep 2020 | - | $510.95M(-10.7%) |
| Jun 2020 | - | $572.49M(+8.3%) |
| Mar 2020 | - | $528.73M(-11.0%) |
| Dec 2019 | $594.33M(+69.5%) | $594.33M(-10.4%) |
| Sep 2019 | - | $663.65M(+35.8%) |
| Jun 2019 | - | $488.69M(-4.7%) |
| Mar 2019 | - | $512.94M(+46.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $350.73M(+124.2%) | $350.73M(-9.2%) |
| Sep 2018 | - | $386.09M(+44.4%) |
| Jun 2018 | - | $267.40M(+77.9%) |
| Mar 2018 | - | $150.31M(-3.9%) |
| Dec 2017 | $156.44M(+30.8%) | $156.44M(+7.2%) |
| Sep 2017 | - | $145.88M(-14.1%) |
| Jun 2017 | - | $169.73M(+68.3%) |
| Mar 2017 | - | $100.83M(-15.7%) |
| Dec 2016 | $119.58M(-47.1%) | $119.58M(-14.7%) |
| Sep 2016 | - | $140.18M(-15.4%) |
| Jun 2016 | - | $165.62M(-15.5%) |
| Mar 2016 | - | $196.00M(-13.3%) |
| Dec 2015 | $226.00M(-24.3%) | $226.00M(-16.0%) |
| Sep 2015 | - | $269.15M(+8.3%) |
| Jun 2015 | - | $248.58M(-9.1%) |
| Mar 2015 | - | $273.32M(-8.4%) |
| Dec 2014 | $298.47M(+118.6%) | $298.47M(+48.3%) |
| Sep 2014 | - | $201.30M(-10.0%) |
| Jun 2014 | - | $223.76M(-8.4%) |
| Mar 2014 | - | $244.34M(+78.9%) |
| Dec 2013 | $136.54M(+825.6%) | $136.54M(-9.6%) |
| Sep 2013 | - | $151.03M(-1.2%) |
| Jun 2013 | - | $152.92M(+348.7%) |
| Mar 2013 | - | $34.08M(+277.5%) |
| Dec 2012 | -$18.82M(+22.3%) | -$19.19M |
| Dec 2011 | -$24.22M | - |
FAQ
- What is PTC Therapeutics, Inc. annual stockholders equity?
- What is the all-time high annual shareholders equity for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is PTC Therapeutics, Inc. quarterly stockholders equity?
- What is the all-time high quarterly shareholders equity for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is PTC Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of PTCT is -$1.10B
What is the all-time high annual shareholders equity for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual stockholders equity is $594.33M
What is PTC Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, PTCT annual stockholders equity has changed by -$279.52M (-34.15%)
What is PTC Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of PTCT is -$206.55M
What is the all-time high quarterly shareholders equity for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly stockholders equity is $663.65M
What is PTC Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, PTCT quarterly stockholders equity has changed by +$773.63M (+78.93%)